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New 'freatment Protocol for Feline Oral Squamous Cell Carcinoma 
Squamous cell carcinoma is the most common 
oropharyngeal tumor seen in the older cat. This very 
aggressive disease is treatable by surgery in only about 
50 percent of the patients because it involves the 
tongue or irs base. The median survival rate from time 
of diagnosis is one to three months because the 
animals are eutbanized at that time because of the 
inability to eat. The tumor is usually not diagnosed 
until it has progressed substantially. Owners first 
notice something is amiss when the cat is not 
grooming itself and is reluctant to eat. This tumor is 
very similar to advanced bead and neck cancer in 
humans, which too has a very poor prognosis for 
treatment. OnJy 15 to 30 percent of patients with 
advanced bead and neck live five years or more after 
diagnosis. 
Dr. Sydney Evans. assistant professor of radi­
ology at the School of Veterinary Medicine, Univer­
sity of Pennsylvania, is investigating a treatment 
protocol for feline oral squamous cell carcinoma, 
using a new cell sensitizing drug and radiation 
treatments. Cats with these tumors, when treated by 
mdiation alone, have a median survival rate of four 
months. "It bas long been suspected that the low 
success rate of radiation treatment for these tumors 
has been due to hypoxic tumor cells which are 
radiation resistant," said Dr. Evans. ''Hypoxic cells 
are oxygen poor and they are not easily killed by 
radiation. One can make a hypoxic cell more receptive 
to radiation by administering drugs which change the 
cells' state of oxygenation." Unfortunately, these 
drugs, when given in quantity, are neurotoxic and 
cause damage to central and peripheral nerves. 
Because this tumor in the cat can represent an animal 
model for human head and neck cancer, new treat­
ment modes used in animals can provide a great deal 
of information for new treatment of human patients. 
Dr. Evans and her colleagues studied the effects 
of etanidazole when it is inJected directly into the 
rumor bearing tissue to see whether this method 
could improve the outcome of radiation therapy. 
Eleven cats with measurable oral squamous cell 
tumors were entered in the clinical study. Thoracic 
radiographs were performed. as well as blood tests. 
The tumors were biopsied and staged. Seven of the 
cats also bad skull radiographs while four received an 
MRl. Each cat received 12 radiation treatments, given 
three times a week over 16 weeks. Between treatments 
most of the animals were at home with their owners. 
For each treatment the animals were anesthetized 
so that they would remain still during radiation. 
Thirty minutes prior to radiation treatment, the 
tumor, as well as surrounding normal tissue, was 
injected at 5 mm intervals with etanidazole. The first 
four cats studied received the drug prior to every 
other treatment. The fifth cat received the drug 
injected into the tumor and intravenously on alternate 
treatments. Because no significant toxicity was 
observed. the amount of the drug injected was 
increased for the remaining cats, and the drug was 
administered prior to each radiation treatment. 
In addition, pharmacokinetic studies were con­
ducted in four cats. It was observed that drug levels in 
the plasma peaked 14 minutes after intratumor 
injection. Some of the patients developed self­
limiting fevers and leukopenia (low white blood ceU 
count). After radiation treatments ended, cats were 
seen at regular intervals for examination and/ or 
biopsy of the tumor site. 
In all cats, tumor regression occurred during the 
course of therapy. In most cats this correlated with 
the resolution of anorexia. return of grooming habits 
and stabilization of weight. "The local tumor 
response bas been encouraging, especially in those 
cats with tongue squamous cell carcinoma," said Dr. 
Evans. "For the six cats with the lesion of or under 
A squamous cell c.arclooma prio1 to treJllment. 
Th� sam� site after tl'eafment. 
the tongue who completed the protocol, the median 
time to progression and survival as of early Septem­
ber was 122 days. This compares favorable with the 
data from prvious studies in which the median 
survival rate for cats with tongue squamous cell 
carcinoma is 31 and 91 days respectively." 
Of the 1 1 cats treated, three remain without 
Coping with Loss 
It's 3:30 on a Thesday afternoon, and a small 
group of sad4looking people are gathered in a room at 
the School of Veterinary Medicine. There's the young 
mother who, four weeks ago, bad her much-loved dog 
eutbanized; it was leaking urine all over the bouse; 
after a week of relief, the woman was dragged down 
by an overwhelming guilt about her decision. and not 
giving the dog a proper good by. Her husband sits at 
her side. 
There's a woman whose 20-year-old cat 
screamed every night, for no reason that bad ever 
been diagnosed. The woman, whose apartment 
echoes with quiet now, still feels badly that she didn't 
comfort the cat when, riddled with cancer, it was put 
to sleep; that was several months ago. 
There's another woman who cried so hard when 
her cat died that she burst a blood vessel in her lung 
and bad to be hospitalized. This was the cat that had 
sustained her when her husband died, 12 years ago; 
the cat which had sat with her at the dinner table and 
on the side of the bathtub, which had even accompan­
ied her on a trip to Paris and cruised with her down 
the Seine. 
And what they're all doing is sharing tales about 
the animals that they loved as dearly as people-and 
whose deaths have left them with a hole in their Uves, 
and a palpable grief that feels like it just won't let up. 
"It's important to talk to people who have 
animals," says Katb1een Dunn, M.S.W. a psychiatric 
social worker at the University of Pennsylvania 
School of Veterinary Medicine. She leads the Pet 
Bereavement Support Group at the SchooL. one of few such groups in the United States. ''Other people 
wiU tolerate you for a while, but then will often say 
evidence of local tumor progression. Five cats have 
had local recurrence at 55, 125, l39, 202, and 331 
days post treatment and have been euthanized. Three 
cats died, one due to pulmonary metastases, pulmon­
ary thromboembolism and pneumonia, one due to a 
tracheal obstruction, and one due to osteonecrosis. 
This can be compared to previous studies of radiation 
alone, where the recurrence is reported at 46 to 142 
days following diagnosis. Six animals were autopsied 
and viable and necrotic rumor cells were found at the 
treatment site. 
• 'We chose to investigate the IT route of drug 
administration because we expected it to result in an 
optimal ratio of tumor response to normal tissue 
toxicity, .. said Dr. Evans. "The IT route for radiosen­
sitizers was of particular interest in light of previous 
data which suggested that failure to improve outcome 
resulted from the inability to achieve adequate tumor 
drug levels before dose-limiting neurotoxicity. •' 
While this treatment does not offer a cure, it 
does provide a longer quality Life for these feline 
patients. When the tumor recurs, no further treat­
ment is given and the animal is euthanized. Dr. Evans 
said that "the present study had encouraged contin­
ued technical and dosing modification of IT etanida­
zole administration in feline squamous cell carcinoma 
and other animal tumor models. While IT therapy 
alone is promising as a route of administration in 
easily accessible, well visuali.zed lesions, it may, in the 
future, have an even more important role in supple­
menting systemic administration, particularly of 
bulky, hypoxic tumor sites." The study was a joint 
project with the Fox Chase Cancer Institute. Jn 
addition to Dr. Evans, Ur. Stuart Helland and Or. 
Thomas Van Winkle, and Deborah Allen, from the 
Veterinary School worked on the project. 
something hurting, like 'It was only an animal; why 
not get another one'? '' 
Although often incomprehensible to non-pet 
owners, a pet's death can be as devastating as the 
death of an important human being. "People some­
times feel a sadness so terrible that they think they'll 
never get over it," says Dunn, who is "on call" 
24-bours a day for emergency cases. 
The reason for this pain is the depth of the bond 
that's formed between most pet owners and their 
animal companions. ·'What happens when you select 
a pet is that you get very attached," Dunn says, "The 
relationship consists of lots of love and joy and fun 
- and, as I hear a lot, the uncondiHonal love you get 
back from your pet. Because this bond is so deep, the 
animal becomes a person to you, part of the family­
sort of a perennial two-year-old. And if the relation­
ship is threatened by death or illness, it's like a child 
dying. It doesn't matter that what died was 'only' an 
animal; a loss is a loss is a loss." 
The death of an animal can also stir up the 
memories of losing an important human being. 
"Someone in the group might say; 'I'm feeling as 
bad, or worse, than when my mother died," Dunn 
says. The stages of the mourning and grieving process 
that a pet owner goes through is analogous to the 
process made famous by death-and-dying expert 
Elizabeth Kubler-Ross. Pet owners often experience 
anger, either at the veterinarian who couldn't "save" 
their pet, or at themselves for not taking certain steps 
that might have prevented their animal's demise. At 
another point they may feel guilty, because they 
didn't follow their veterinarian's advice exactly, or 
because they chose to euthanize a failing animal that 
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